Shareholding disclosure

Credit Suisse Group AG

Declared position

Threshold

Fell below threshold

Timeline

Published

09.03.2017

Transaction

01.03.2017

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH3800010

Beneficial owner

Credit Suisse Group AG

Declared address

Credit Suisse Group AG, Zürich

Rückgabe von Effektenleihe

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Group AG

Basilea Pharmaceutica AG, Allschwil09.03.2017TAH3800010

Disclosure summary

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil that fell below the publication threshold, published by SIX Exchange Regulation on 09.03.2017, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Group AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 09.03.2017.

Publication date09.03.2017

Transaction date01.03.2017

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerCredit Suisse Group AG

Declared addressCredit Suisse Group AG, Zürich

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAH3800010

Commercial register

CHE-105.884.494

Struck off the register · 14.06.2023

Zefix record

Conditions

Rückgabe von Effektenleihe

Source: SIX Exchange Regulation · Publication date: 09.03.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open